Seth Pollack, MD, is an expert sarcoma specialist with a passion for helping patients with desmoid tumors. He is currently serving as the Director of the Sarcoma Program at the Lurie Cancer Center and the Steven T. Rosen Professor of Cancer Biology at the Feinberg School of Medicine at Northwestern University. As a physician-scientist, he is developing novel immunotherapies for patients with advanced sarcoma and leveraging unique features of sarcoma immunobiology to improve immunotherapy for all patients with cancer.
As a clinician and sarcoma expert, he has chaired sessions at the annual meetings of the American Society of Clinical Oncology (ASCO), the Japanese Society for Medical Oncology (JSMO), the Connective Tissue Oncology Society (CTOS) and gave the keynote talk at the 2019 Annual Meeting of the British Sarcoma Group. Some of his awards have included the V Foundation Translational Award, the Alliance for Cancer Gene therapy, grants from the Sarcoma Foundation of America and the SARC Career Development Award. His research is funded by the National Institutes of Health and the Department of Defense.
He sits on the NCCN guidelines panel for soft tissue sarcomas which includes the national guidelines for desmoid tumors. During his 12 years treating patients with sarcoma at the University of Washington and Fred Hutchinson Cancer Research Center, he received the Sig Kohl Legacy award from the Northwest Sarcoma Foundation for an “outstanding and enduring contribution to the care of sarcoma patients in the Northwest.” He is thrilled to be living in Chicago and helping patients suffering from desmoid tumors at the Lurie Cancer Center.